chr1-46196937-A-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_017739.4(POMGNT1):c.235+33T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0242 in 1,614,094 control chromosomes in the GnomAD database, including 808 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.041 ( 203 hom., cov: 33)
Exomes 𝑓: 0.022 ( 605 hom. )
Consequence
POMGNT1
NM_017739.4 intron
NM_017739.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.318
Publications
4 publications found
Genes affected
POMGNT1 (HGNC:19139): (protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)) This gene encodes a type II transmembrane protein that resides in the Golgi apparatus. It participates in O-mannosyl glycosylation and is specific for alpha linked terminal mannose. Mutations in this gene may be associated with muscle-eye-brain disease and several congenital muscular dystrophies. Alternatively spliced transcript variants that encode different protein isoforms have been described. [provided by RefSeq, Feb 2014]
POMGNT1 Gene-Disease associations (from GenCC):
- autosomal recessive limb-girdle muscular dystrophy type 2OInheritance: AR Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: G2P, Ambry Genetics, Orphanet
- muscle-eye-brain diseaseInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3Inheritance: AR Classification: DEFINITIVE, LIMITED Submitted by: G2P, Ambry Genetics
- myopathy caused by variation in POMGNT1Inheritance: AR Classification: STRONG Submitted by: ClinGen
- retinitis pigmentosa 76Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital muscular dystrophy with cerebellar involvementInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-46196937-A-C is Benign according to our data. Variant chr1-46196937-A-C is described in ClinVar as Benign. ClinVar VariationId is 260873.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0831 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0409 AC: 6228AN: 152108Hom.: 203 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
6228
AN:
152108
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0291 AC: 7319AN: 251488 AF XY: 0.0292 show subpopulations
GnomAD2 exomes
AF:
AC:
7319
AN:
251488
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0225 AC: 32831AN: 1461868Hom.: 605 Cov.: 33 AF XY: 0.0231 AC XY: 16763AN XY: 727242 show subpopulations
GnomAD4 exome
AF:
AC:
32831
AN:
1461868
Hom.:
Cov.:
33
AF XY:
AC XY:
16763
AN XY:
727242
show subpopulations
African (AFR)
AF:
AC:
3182
AN:
33480
American (AMR)
AF:
AC:
605
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
777
AN:
26136
East Asian (EAS)
AF:
AC:
22
AN:
39700
South Asian (SAS)
AF:
AC:
3792
AN:
86256
European-Finnish (FIN)
AF:
AC:
3261
AN:
53408
Middle Eastern (MID)
AF:
AC:
152
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
19446
AN:
1112002
Other (OTH)
AF:
AC:
1594
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
2577
5154
7730
10307
12884
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
812
1624
2436
3248
4060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0409 AC: 6232AN: 152226Hom.: 203 Cov.: 33 AF XY: 0.0422 AC XY: 3143AN XY: 74436 show subpopulations
GnomAD4 genome
AF:
AC:
6232
AN:
152226
Hom.:
Cov.:
33
AF XY:
AC XY:
3143
AN XY:
74436
show subpopulations
African (AFR)
AF:
AC:
3549
AN:
41526
American (AMR)
AF:
AC:
325
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
107
AN:
3466
East Asian (EAS)
AF:
AC:
7
AN:
5180
South Asian (SAS)
AF:
AC:
214
AN:
4822
European-Finnish (FIN)
AF:
AC:
713
AN:
10616
Middle Eastern (MID)
AF:
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1236
AN:
68004
Other (OTH)
AF:
AC:
70
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
304
608
912
1216
1520
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
96
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Retinitis pigmentosa 76 Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.